ArticleCancer biomarkers : section A of Disease markers2016

Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.

Vincenzo Formica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.